• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sci Adv . Durable reprogramming of neutralizing antibody responses following Omicron breakthrough infection

tetano

Editor, Senior Moderator
Sci Adv


. 2023 Jul 21;9(29):eadg5301.
doi: 10.1126/sciadv.adg5301. Epub 2023 Jul 21. Durable reprogramming of neutralizing antibody responses following Omicron breakthrough infection

Wen Shi Lee[SUP] 1 [/SUP], Hyon-Xhi Tan[SUP] 1 [/SUP], Arnold Reynaldi[SUP] 2 [/SUP], Robyn Esterbauer[SUP] 1 [/SUP], Marios Koutsakos[SUP] 1 [/SUP], Julie Nguyen[SUP] 1 [/SUP], Thakshila Amarasena[SUP] 1 [/SUP], Helen E Kent[SUP] 1 [/SUP], Anupriya Aggarwal[SUP] 2 [/SUP], Stuart G Turville[SUP] 2 [/SUP], George Taiaroa[SUP] 3 4 [/SUP], Paul Kinsella[SUP] 3 [/SUP], Kwee Chin Liew[SUP] 3 [/SUP], Thomas Tran[SUP] 3 [/SUP], Deborah A Williamson[SUP] 3 4 [/SUP], Deborah Cromer[SUP] 2 [/SUP], Miles P Davenport[SUP] 2 [/SUP], Stephen J Kent[SUP] 1 5 [/SUP], Jennifer A Juno[SUP] 1 [/SUP], David S Khoury[SUP] 2 [/SUP], Adam K Wheatley[SUP] 1 [/SUP]



Affiliations
Free PMC article Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) breakthrough infection of vaccinated individuals is increasingly common with the circulation of highly immune evasive and transmissible Omicron variants. Here, we report the dynamics and durability of recalled spike-specific humoral immunity following Omicron BA.1 or BA.2 breakthrough infection, with longitudinal sampling up to 8 months after infection. Both BA.1 and BA.2 infections robustly boosted neutralization activity against the infecting strain while expanding breadth against BA.4, although neutralization activity was substantially reduced for the more recent XBB and BQ.1.1 strains. Cross-reactive memory B cells against both ancestral and Omicron spike were predominantly expanded by infection, with limited recruitment of de novo Omicron-specific B cells or antibodies. Modeling of neutralization titers predicts that protection from symptomatic reinfection against antigenically similar strains will be durable but is undermined by new emerging strains with further neutralization escape.


 
Back
Top Bottom